- Doctors & Departments
- Conditions & Advice
- Your Visit
- Research & Innovation
Craniopharyngioma is an uncommon, slow-growing brain tumor that can occur in children or adults. Craniopharyngioma always occurs in the same location, known as the sellar/suprasellar region. This region is located just behind and between the eyes.
There are two types of craniopharyngioma: adamantinomatous and papillary. Children with craniopharyngioma almost always have the adamantinomatous subtype. These tumors usually have some areas that are solid and some areas that are cystic (made up of pockets of trapped fluid).
Craniopharyngioma tumors do not spread to other parts of the body. The risk associated with a craniopharyngioma tumor is injury to important structures of the brain that are located near where the tumor grows.
The cause of craniopharyngioma is unknown. Experts at Children’s Hospital Colorado are currently involved in research to discover the cells from which craniopharyngioma originates.
Some evidence indicates that these tumors originate from the pituitary gland (a small structure at the base of the brain, behind and between the eyes, that secretes hormones that help keep the body healthy). Other evidence suggests that craniopharyngioma may arise from a developmental structure called the craniopharyngeal duct (or Rathke's pouch).
Craniopharyngioma does not run in families, nor is it caused by exposure to anything specific in the environment, such as a child’s diet.
Craniopharyngioma occurs in both children and adults. Approximately half of craniopharyngiomas are diagnosed in children less than 18 years of age. Among children, it is most frequent between the ages of 5-14. Craniopharyngioma accounts for about 3-9% of all pediatric central nervous system tumors.
There is no clear association of craniopharyngioma with a particular gender, race or geographic region.
Craniopharyngiomas are usually not discovered until they press on important surrounding structures in the brain. While these tumors are sometimes referred to as benign (which means they are not cancerous and will not spread to other parts of the body), they are an issue because they grow within the closed box of the skull.
Craniopharyngiomas have a tendency to become attached to or push on the critical brain structures that surround the area where they grow.
There are three general groups of signs/symptoms that typically bring craniopharyngioma tumors to medical attention: headaches, endocrine (hormone-related) and visual changes. Other areas that can be affected are the hypothalamus, blood vessels and cerebrospinal fluid (CSF) pathways (the fluid surrounding the brain and spinal cord).
The signs and symptoms produced by a craniopharyngioma vary depending upon the structures that are most effected. Headaches are a common general symptom, but do not occur in everyone.
Medical history and physical exam
The most important tests include a neurological and physical exam, in addition to reviewing your child’s medical history. During this exam, the doctor will ask questions about your child's behavior and discuss any physical changes.
Doctors may ask to test your child’s blood in order to look for signs of hormone dysfunction, which can occur with a craniopharyngioma brain tumor.
Doctors may ask to take radiographic images of your child’s brain. The two most common tests are a computed tomogram (CT) and magnetic resonance imaging (MRI). These studies provide detailed information about the brain.
If there is evidence of a craniopharyngioma, our neurosurgeons may need to perform an operation to confirm what kind of cells are growing and help improve your child’s symptoms.
Because craniopharyngioma is a tumor that can be approached many different ways, surgery is tailored to the specific needs of each patient.
The initial treatment for craniopharyngioma almost always includes surgery. Our team at Children’s Hospital Colorado is highly specialized and performs many brain tumor operations each month.
The goal of surgery for craniopharyngioma is determined by each patient’s specific characteristics. When the risk of injury is low, the goal is to completely remove the tumor. When there is more risk, the goal may be to sample enough tissue to obtain a diagnosis, while also improving the symptoms that brought the patient to medical attention. We make all decisions regarding the goals and approach for surgery together with the patient and family.
Each patient is evaluated individually. When complete surgical removal is not in the patient’s best interest, surgery may be supplemented with radiation treatment, which generally offers excellent control of tumor growth.
Because hormone and visual problems can develop as a result of craniopharyngioma, all of our patients are cared for by a multidisciplinary team of pediatric specialists. These include experts in neurosurgery, neuro-oncology, endocrinology, ophthalmology, neurology, neuropsychology, physical medicine and rehabilitation. Our team follows children with craniopharyngioma in a single, unified program (Neuro-Oncology Program within the multidisciplinary clinic) where the patient and family can see all the specialists in one afternoon. This clinic is offered twice monthly.
Our Neurosurgery Program and Neuro-Oncology Program are the only clinics in the Rocky Mountain region where your child can get state-of-the-art treatment for a pediatric brain tumor. Our doctors and nurse practitioners are known internationally for their expertise in diagnosing, treating and caring for kids and young adults with craniopharyngioma.
We offer the only dedicated pediatric radiation oncologist in the region, which means our sole focus is radiation therapy for kids. Our radiation therapy is planned and administered for the sensitive nature of a child's growing brain. Because your child's brain is still developing, it is important that the radiation doctor knows exactly what, where and how much radiation to deliver to the tumor.
Doctors and nurses who specialize in anesthesia will take care of your child during radiation. You can feel comfortable knowing that our pediatric staff will sedate your child to help him/her sleep and lie still so the radiation goes to exactly the right spot.
Lastly, Children’s Hospital Colorado is the home institution of the Advancing Treatment for Pediatric Craniopharyngioma (ATPC) Consortium. This consortium is dedicated to the identification of improved treatments for children with craniopharyngioma, and was initially funded thanks to The Morgan Adams Foundation Pediatric Brain Tumor Research Program.
With permission from patients and their families, member institutions share tumor tissue and information regarding the patient’s treatment and symptoms with researchers at Children’s Colorado/University of Colorado, led by our pediatric neurosurgeon Dr. Todd Hankinson.
In the research laboratories, we use sophisticated methods to study the unique characteristics of these tumors. ATPC is the only consortium in North America dedicated only to the study of pediatric craniopharyngioma.
Neurology - Pediatric
Hematology/Oncology - Pediatric , Pediatrics
Hematology/Oncology - Pediatric , Pediatrics